NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists
- 14 August 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 219 (1) , 45-52
- https://doi.org/10.1016/0014-2999(92)90578-r
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of actionPublished by Elsevier ,2002
- Dopamine receptor subtypes: beyond the D1/D2 classificationTrends in Pharmacological Sciences, 1990
- Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brainEuropean Journal of Pharmacology, 1988
- Evidence for Different States of the Dopamine Dl Receptor: Clozapine and Fluperlapine May Preferentially Label an Adenylate Cyclase-Coupled State of the Dl ReceptorJournal of Neurochemistry, 1986
- Specific binding of 3H-SCH 23390 to dopamine D1 receptorsLife Sciences, 1986
- Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivoEuropean Journal of Pharmacology, 1986
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- SCH 23390—The first selective dopamine D-1 antagonistEuropean Journal of Pharmacology, 1983